NEPHROPLUS
Nephrocare Health Services LimitedNSEMarket Closed · NSE · INR
Open
₹629.95
High
₹640.25
Low
₹618
Prev Close
₹628.8
Market Cap
₹6323.15 Cr
Mid Cap
P/E (TTM)
48.67
EPS
₹12.92
Div Yield
-
P/B Ratio
5.64
ROE
11.2%
Key Metrics
Analyst Ratings(4 analysts)
Target Price
₹771
+23.1% upside
Current price: ₹627
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Recent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.